Personalized probiotics are revolutionising the gut health market, and they are the future of gut health optimization. When administered in sufficient proportions, probiotics are live organisms that are good to the host and provide health advantages. Their mechanisms of action include microbial community management, pathogen suppression, immunomodulation, epithelial cell proliferation, and gut barrier fortification. The popularity of probiotics in recent years has flooded the market, leaving consumers with hundreds of choices but no information. Traditional probiotic production methods rely on limited data or extrapolate data from a small sample size of healthy persons, making them unsuitable for our microbiomes. This probiotic is targeted at missing probiotic strains, enhancing the microbiome to produce a diversified and dynamic community that promotes inner harmony and general health. This is accomplished by eliminating harmful bacteria and optimising the gut environment so that beneficial microbes can grow and assist the host body.
Title : Overcoming manufacturing challenges in next-generation probiotics: From anaerobic cultivation to clinical-grade formulation
Jason Ryan, Sacco System, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic – results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium